학술논문
'학술논문'
에서 검색결과 109,810건 | 목록
1~20
eBook
Buckwheat: Methods and Protocols. 03/27/2024. 2791:1-14
eBook
Traverse, Krystyna K. F.; Mortensen, Samuel; Trautman, Juliet G.; Danison, Hope; Rizvi, Noreen F.; Lee-Parsons, Carolyn W. T.
Plant Secondary Metabolism Engineering: Methods and Protocols. 05/05/2022. 2469:129-144
eBook
Plant Gene Silencing: Methods and Protocols. 03/25/2022. 2408:303-316
eBook
Plant Circadian Networks: Methods and Protocols. 10/22/2021. 2398:65-73
Academic Journal
Kaweme, Natasha Mupeta; Butress, Sahar Mounir Nagib; Akekelwa, Inonge; Kowa, Sumbukeni Francis; Mantina, Hamakwa Muluti; Mwandama, Charles Kapela; Minh, Le
Academic Journal
eBook
Legume Genomics: Methods and Protocols. 01/01/2020. 2107:335-348
Academic Journal
한국해양공학회지. 2025-04 39(2):133-141
Report
Clinical Research in Hairy Cell Leukemia: Surveillance and Documentation of Clinical Outcomes in a Rare Form of Adult Leukemia
Academic Journal
Zarev, Yancho; Nedelcheva, Rada; Todorova, Teodora; Boyadzhiev, Krassimir; Dimitrov, Martin; Ionkova, Iliana
Revista Brasileira de Farmacognosia: Brazilian Journal of Pharmacognosy. 35(4):798-809
Academic Journal
International Journal of Tropical Insect Science. 45(3):1341-1361
Academic Journal
Peralta, Lauren; Khan, Muneer; Meseeha, Marcelle G.; Richards, Julie L.; Poulose, Joyson; Talamo, Giampaolo
Report
A Phase I Study of Moxetumomab Pasudotox-tdfk (Lumoxiti (TM)) and Either Rituximab (Rituxan (R)) or Ruxience for Relapsed Hairy Cell Leukemia
Report
A Phase 2 Study of Venetoclax in Relapsed Classic or Variant Hairy Cell Leukemia
Report
Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant
Report
Phase II Study of 2-Chlorodeoxyadenosine (2CDA) Followed by Rituximab in Hairy Cell Leukemia
Ravandi F, O'Brien S, Jorgensen J, Pierce S, Faderl S, Ferrajoli A, Koller C, Challagundla P, York S, Brandt M, Luthra R, Burger J, Thomas D, Keating M, Kantarjian H. Phase 2 study of cladribine followed by rituximab in patients withhairy cell leukemia. Blood. 2011 Oct 6;118(14):3818-23. doi: 10.1182/blood-2011-04-351502. Epub 2011 Aug 5.
Ravandi F, O'Brien S, Jorgensen J, Pierce S, Faderl S, Ferrajoli A, Koller C, Challagundla P, York S, Brandt M, Luthra R, Burger J, Thomas D, Keating M, Kantarjian H. Phase 2 study of cladribine followed by rituximab in patients with
Report
A Phase 1b Study of Combination Tovorafenib (DAY101) and Rituximab Treatment in Relapsed or Refractory Classical Hairy Cell Leukemia and Phase 2 Randomized Study Comparing Tovorafenib (DAY101) and Rituximab With Cladribine and Rituximab for Front-Line Treatment of Classical Hairy Cell Leukemia
Report
Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
Bouroncle BA. Thirty-five years in the progress ofhairy cell leukemia. Leuk Lymphoma. 1994;14 Suppl 1:1-12.
Kreitman RJ, Cheson BD. Malignancy: Current Clinical Practice: Treatment ofHairy Cell Leukemia at the Close of the 20th Century. Hematology. 1999;4(4):283-303. doi: 10.1080/10245332.1999.11746452.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66. doi: 10.3322/canjclin.57.1.43.
Bouroncle BA. Thirty-five years in the progress of
Kreitman RJ, Cheson BD. Malignancy: Current Clinical Practice: Treatment of
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66. doi: 10.3322/canjclin.57.1.43.
검색 결과 제한하기
제한된 항목
[검색어] HAIRY
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어